Delivery Order SPE2DB22D3301-SPE2DB25FZ1KC
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $9,288.90 by the Defense Logistics Agency for BIKTARVY 30-120-15 mg tablets (30-count supply). The contract, awarded on April 23, 2025, with an ultimate completion date of April 24, 2025, carries firm fixed pricing and represents a competitive award with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $31,715.77 by the Defense Logistics Agency on July 22, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed price contract carries an ultimate completion date of July 23, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $55,560.43 for BIKTARVY 50-200-25 mg tablets (30-count units) by the Defense Logistics Agency on September 9, 2025. This firm fixed price, competitively awarded contract with no set-aside designation is scheduled for completion by September 10, 2025, with performance taking place at the company's Conshohocken facility. The award represents a child...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $210,550.92 on September 27, 2025, for the supply of BIKTARVY 50-200-25 mg tablets (30-count units) to support the Defense Logistics Agency's Medical Supply Chain. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency valued at $51,148.62 for Biktarvy 50-200-25 mg tablets (30-count units). The contract is a firm fixed price delivery order with a completion date of July 29, 2025, and was awarded on July 28, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $159,128.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with an ultimate completion date of September 15, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) valued at $8,263.10 for Biktarvy 50-200-25 mg tablets (30-count units). The award, made on August 6, 2025, represents a firm fixed-price, non-set-aside contract with an ultimate completion date of August 7, 2025. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) under a firm fixed-price contract valued at $8,767.12. The award, made on September 19, 2025, with a completion date of September 22, 2025, was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $73,229.67 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract fulfilling federal pharmaceutical procurement requirements. The award was placed to AmerisourceBergen's Corporate Office located in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 7, 2025, by the Defense Logistics Agency for $50,225.55 to supply Biktarvy 50-200-25 mg tablets in quantities of 30. This firm fixed-price delivery order, which is not set-aside designated, is expected to be completed by August 8, 2025, and will be performed at the contractor's Conshohocken facility. The award represents a continuation of...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ1KCDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $128,852.06 for the supply of BIKTARVY 50-200-25 mg tablets in packages of 30 units. Awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, this firm fixed-price contract represents a competitive award with no set-aside designation. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 pharmaceutical prime vendor agreement running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award supports the Defense Health Agency and other federal healthcare systems through AmerisourceBergen's established role as a critical pharmaceutical distributor for the federal government. BIKTARVY is an antiretroviral medication used in HIV treatment, reflecting the company's portfolio encompassing specialty medications across multiple therapeutic domains. The delivery order demonstrates AmerisourceBergen's ongoing capacity to fulfill federal medical procurement requirements, with performance at the company's corporate office location in Conshohocken, Pennsylvania.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $128.9k | 9/23/25 |